首页> 外国专利> process for the manufacture of 18,20 - lactones of 3 - methylamino - 16 amp; alpha; 20 - dihydroxy - 5 (6) - pregnen - 18 - acid of 18,20 - lactones of 3 - dimethylamino - 16 amp; alpha;,20 - dihydroxy - 5 (6) - pregnen - 18 - acid or syreadditionssalte thereof.

process for the manufacture of 18,20 - lactones of 3 - methylamino - 16 amp; alpha; 20 - dihydroxy - 5 (6) - pregnen - 18 - acid of 18,20 - lactones of 3 - dimethylamino - 16 amp; alpha;,20 - dihydroxy - 5 (6) - pregnen - 18 - acid or syreadditionssalte thereof.

机译:制备18,20-3-甲基氨基-16和α的内酯的方法; 20-二羟基-5(6)-怀孕-18-18,20的酸-3-二甲基氨基的内酯-16和α;,20-二羟基-5(6)-怀孕的18-酸或其syreadditionssalte。

摘要

The invention comprises (1) compounds of the formula: FORM:0952484/C2/1 (wherein P and Q each is a hydrogen atom or together they form a double bond; R is a hydrogen atom, an alkyl radical of at most 5 carbon atoms or an acetyl radical; Y is an acetyl radical or a hydrogen atom or, together with B, a bond with the 18-carbon atom; Z is a hydrogen atom or an acetyl radical or, together with A and when B is not a hydrogen atom, a second bond with the 18-carbon atom; A is a hydrogen atom or, together with Z, a double bond; B is a hydrogen atom, the radical OR2 (provided that Z is not a hydrogen atom or an acetyl radical when A is a hydrogen atom) R2 being a hydrogen atom or an alkyl radical, or, together with Y (provided that Z is not a hydrogen atom or an acetyl radical, when A is a hydrogen atom) a bond of the 18-carbon atom to the oxygen on the 20-carbon atom; T is a hydrogen atom, or together with S, a double bond; S is a hydrogen atom or together with T, forms a double bond or, together with X, is a =O, =NOH or ethylenedioxy radical; X is a hydroxyl group, an alkoxy radical of at most 5 carbon atoms, an acetoxy radical or, together with S, is a =O, =NOH or ethylenedioxy radical); and the preparation of paravallarine i.e. (20S)-3 b -N-methylamino-20-hydroxy -18- oie lactone (--20)-pregna-5-ene, N-methyl-paravallarine, paravallaridine i.e. 16a -hydroxy-paravallarine, and N-methyl-paravallaridine wherein parts of the plant Paravallaris microphylla Pitard are crushed, reduced to powder and the powder is made alkaline, the mixture is extracted with an organic solvent which is immiscible with water, other than an alcohol having more than 5 carbon atoms, the bas alkaloids contained in the organic phase are converted into oxalates by treatment with a solution of oxalic acid in water, an alcohol or a ketone of at most 5 carbon atoms and the oxalates are filtered off and converted to the bases. This process may contain a further purification stage in which the alkaloids contained in the organic phase are extracted with a dilute mineral acid, the solution is made alkaline, and the precipitated alkaloids are dissolved in a solvent as described above and then converted to their oxalates. The paravallaridine may be extracted from the other bases by benzene, the paravallaridine alone being insoluble. The remaining bases may then be separated by chromatography or fractional crystallization, for example in acetone or methyl ethyl ketone. Examples describe this process and also the following: paravallaridine, formic acid and formaldehyde give N-methyl-paravallaridine, which on acetylation gives the 16-acetate, on reduction with lithium aluminium hydride gives (20S) -3b -N-dimethylamino-16a , 18, 20-trihydroxy-pregna-5-ene from which a triacetate is prepared, and on catalytic hydrogenation gives the 4, 5-dihydro-derivative; paravallaridine is heated with acetic anhydride to give the diacetyl derivative this on partial hydrolysis gives the mono-N-acetyl compound, this on heating with alcoholic potash gives (20S)-3b -N-methyl-N-acetylamino-16a , 20-dihydroxy-18-oic pregn-5-ene and this with diazomethane gives the methyl ester; paravallaridine is catalytically hydrogenated to dihydroparavallaridine, this with acetic anhydride gives the diacetyl derivative, this on partial hydrolysis gives the N-mono-acetyl derivative, this on oxidation gives 16-oxo-N-acetyl-dihydroparavallarine (which gives an oxime), this is converted to the 16-ethylene ketal and this on lithium aluminium hydride reduction gives (20S)-3b -N-methyl-N-ethylamino-16-oxo-18, 20-dihydroxy-5a -pregnane; N-methyl-dihydroparavallaridine is (a) converted to the 16-acetate, (b) reduced to (20S)-3b -N-dimethyl-amino-16a , 18, 20-trihydroxy-5a -pregnane, and (c) oxidized to 16-oxo-N-methyl-dihydroparavallarine which on LiAlH4 reduction gives (20S) - 3b - N - dimethylamino - 16b ,18,20 - tri -hydroxy -5a - pregnane or, without heating, 16-epi-N-methyl-dihydroparavallaridine; 16-oxo-N-acetyl-dihydroparavallarine is reduced with zinc amalgum to N-acetyl -D 15- dihydroparavallarine, this is hydrogenated to N-acetyl-dihydroparavallarine (which is also prepared by acetylation of dihydroparavallarine) or is reduced by LiAlH4 to (20S)-3b -N-methyl-N-ethylamino-18, 20-dihydroxy-5a -pregna-15-ene, either of which can be reduced to (20S) -3b -N-methyl-N-ethylamino-18, 20-dihydroxy-5a -pregnane; and 16-oxo-N-methyl-paravallarine gives on zinc amalgum reduction N-methyl-D 15-dihydroparavallarine which on catalytic hydrogenation gives N-methyl-dihydroparavallarine (also obtained by methylation of dihydroparavallarine. The conversion of paravallaridine to its hydrochloride is also described. Specification 913,602 is referred to.
机译:本发明包含(1)下式的化合物:(其中P和Q各自为氢原子或一起形成双键; R为氢原子,至多为烷基5个碳原子或一个乙酰基; Y是一个乙酰基或一个氢原子,或与B一起与18个碳原子键合; Z是一个氢原子或一个乙酰基,或与A一起,当B为不是氢原子,是与18个碳原子的第二个键; A是氢原子,或者与Z一起是双键; B是氢原子,是基团OR2(前提是Z不是氢原子或当A为氢原子时为乙酰基)R2为氢原子或烷基,或与Y(假设A为氢原子时Z不是氢原子或乙酰基)一起与18 -碳原子与20个碳原子上的氧原子相连; T是氢原子,或与S一起形成双键; S是氢原子或与T一起形成双键或与X一起的是= O,= NOH或乙二氧基。 X是羟基,至多5个碳原子的烷氧基,乙酰氧基或与S一起是= O,= NOH或乙二氧基);并制备了巴拉伐拉汀,即(20S)-3 b -N-甲基氨基-20-羟基-18-oie内酯(-> 20)-孕烯-5-烯,N-甲基-巴拉伐拉明,对巴拉拉啶,即16a-羟基-其中将部分植物Paravallaris microphylla Pitard压碎,还原成粉末并将粉末制成碱性,然后将其用与水不混溶的有机溶剂萃取(混合物中的醇除外)通过用草酸在水中的溶液,至多5个碳原子的醇或酮的处理,将有机相中包含的5个碳原子的碱生物碱转化为草酸酯,并过滤掉草酸酯并转化为碱。该方法可包含进一步的纯化步骤,其中用稀无机酸萃取有机相中所含的生物碱,使溶液呈碱性,并将沉淀的生物碱如上所述溶解于溶剂中,然后转化为它们的草酸盐。可以通过苯从其他碱中提取对戊二酰吡啶,仅对戊二酰赖氨酸是不溶的。然后可以通过色谱法或分步结晶,例如在丙酮或甲基乙基酮中,分离剩余的碱。实施例描述了该方法,还描述了以下方法:巴拉瓦拉定,甲酸和甲醛生成N-甲基-巴拉瓦拉定,乙酰化后生成16-乙酸酯,氢化铝锂还原后生成(20S)-3b -N-二甲基氨基-16a, 18,由其制备三乙酸酯的20-三羟基-孕烯-5-烯,经催化氢化得到4,5-二氢衍生物。将对戊拉啶与乙酸酐加热,得到二乙酰基衍生物,部分水解后得到单-N-乙酰基化合物,与乙醇钾加热后得到(20S)-3b -N-甲基-N-乙酰氨基-16a,20-二羟基-18-o-pregn-5-ene与重氮甲烷反应生成甲酯;将对羟基戊烷催化氢化为二氢对羟基戊啶,与乙酸酐反应生成二乙酰基衍生物,在部分水解时得到N-单乙酰基衍生物,在氧化时得到16-氧代-N-乙酰基-二氢对戊二酸(生成肟),这转化为16-乙烯缩酮,并在氢化铝锂上还原得到(20S)-3b-N-甲基-N-乙基氨基-16-氧代-18,20-二羟基-5a-孕烯; N-甲基-二氢对戊二酰(a)转化为16-乙酸酯,(b)还原为(20S)-3b -N-二甲基-氨基-16a,18、20-三羟基-5a-孕烯,和(c)氧化生成16-氧代-N-甲基-二氢对戊二酸,经LiAlH4还原可得到(20S)-3b-N-二甲基氨基-16b,18,20-三羟基-5a-孕烷,或在不加热的情况下,生成16-表-N-甲基-二氢对戊二酰吡啶;将16-氧代-N-乙酰基-二氢对戊二酸与锌合剂还原为N-乙酰基-D 15-二氢对戊二酸,再将其氢化成N-乙酰基-二氢对戊二酸(也通过二氢对戊二酸的乙酰化制得)或通过LiAlH4还原为( 20S)-3b -N-甲基-N-乙基氨基-18,20-二羟基-5a -pregna-15-ene,它们中的任何一个都可以还原为(20S)-3b -N-甲基-N-乙基氨基-18, 20-二羟基-5a-孕烯; 16-氧代-N-甲基-巴拉伐拉林可还原锌锌盐,N-甲基-D 15-二氢巴拉拉碱可催化加氢生成N-甲基-二氢巴拉伐拉明(也可通过二氢巴拉伐拉明的甲基化反应而获得。请参考规范913,602。

著录项

  • 公开/公告号DK105156C

    专利类型

  • 公开/公告日1966-08-29

    原文格式PDF

  • 申请/专利权人 ROGER BELLON;

    申请/专利号DK19620000604

  • 发明设计人 ROGER BELLON;

    申请日1962-02-08

  • 分类号C07C169/26;

  • 国家 DK

  • 入库时间 2022-08-23 15:20:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号